Class III · Low riskOngoing Initiated May 14, 2026 (4 months ago)
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
What was recalled
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.
Recalling firm
AVEVA Drug Delivery Systems, Inc.
NDC code
0536-5895-88
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0550-2026
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the…
P & L Developments, LLCNDC 11822-3328-3D-0004-2021